Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference65 articles.
1. Mato A, Jahnke J, Li P, et al. Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era. Haematologica. 2018;103(10):e462–5. https://doi.org/10.3324/haematol.2017.185868.
2. Surveillance, Epidemiology, and End Results (SEER). SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute. Data source(s): SEER Incidence Data, November 2022 Submission (1975-2020), SEER 22 registries. 2023. https://seer.cancer.gov/statistics-network/explorer/. [updated: 2023 Jun 8; cited 2023 Jun 26]
3. Smolewski P, Robak T. Current treatment of refractory/relapsed chronic lymphocytic leukemia: a focus on novel drugs. Acta Haematologica. 2021;144(4):365–79. https://doi.org/10.1159/000510768.
4. Hallek M, Cheson BD, Catovsky D, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018;131(25):2745–60. https://doi.org/10.1182/blood-2017-09-806398.
5. Eichhorst B, Robak T, Montserrat E, et al. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals Oncol. 2021;32(1):23–33. https://doi.org/10.1016/j.annonc.2020.09.019.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献